{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T06:00:29Z","timestamp":1787032829010,"version":"build-2736575974"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,17]]},"DOI":"10.7759\/cureus.82467","type":"journal-article","created":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T17:25:26Z","timestamp":1744910726000},"source":"Crossref","is-referenced-by-count":1,"title":["Infliximab-Induced Vasculitis in a Rheumatoid Arthritis Patient: A Comprehensive Case Report"],"prefix":"10.7759","author":[{"given":"Thanda","family":"Aung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mia","family":"Celestin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2011.05.044","article-title":"Use of biologics in rheumatoid arthritis: current and emerging paradigms of care","volume":"33","author":"Curtis JR","year":"2011","unstructured":"Curtis JR, Singh JA. Use of biologics in rheumatoid arthritis: current and emerging paradigms of care. Clin Ther. 2011, 33:679-707. 10.1016\/j.clinthera.2011.05.044","journal-title":"Clin Ther"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2007.087288","article-title":"Rates of new-onset psoriasis in patients with rheumatoid arthritis receiving anti-tumour necrosis factor alpha therapy: results from the British Society for Rheumatology Biologics Register","volume":"68","author":"Harrison MJ","year":"2009","unstructured":"Harrison MJ, Dixon WG, Watson KD, King Y, Groves R, Hyrich KL, Symmons DP. Rates of new-onset psoriasis in patients with rheumatoid arthritis receiving anti-tumour necrosis factor alpha therapy: results from the British Society for Rheumatology Biologics Register. Ann Rheum Dis. 2009, 68:209-15. 10.1136\/ard.2007.087288","journal-title":"Ann Rheum Dis"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.17462","article-title":"Leukocytoclastic vasculitis: depiction of the diagnostic dilemma","volume":"13","author":"Bhesania S","year":"2021","unstructured":"Bhesania S, Raol K, Medina C, Ilyas S, Bhesania J, Barmanwalla A. Leukocytoclastic vasculitis: depiction of the diagnostic dilemma. Cureus. 2021, 13:e17462. 10.7759\/cureus.17462","journal-title":"Cureus"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2015-000239","article-title":"Paradoxical reactions under TNF-\u03b1 blocking agents and other biological agents given for chronic immune-mediated diseases: an analytical and comprehensive overview","volume":"2","author":"Toussirot \u00c9","year":"2016","unstructured":"Toussirot \u00c9, Aubin F. Paradoxical reactions under TNF-\u03b1 blocking agents and other biological agents given for chronic immune-mediated diseases: an analytical and comprehensive overview. RMD Open. 2016, 2:e000239. 10.1136\/rmdopen-2015-000239","journal-title":"RMD Open"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.5790","article-title":"Rheumatoid vasculitis: Is it always a late manifestation of rheumatoid arthritis?","volume":"11","author":"Anwar MM","year":"2019","unstructured":"Anwar MM, Tariq EF, Khan U, Zaheer M, Ijaz SH. Rheumatoid vasculitis: Is it always a late manifestation of rheumatoid arthritis?. Cureus. 2019, 11:e5790. 10.7759\/cureus.5790","journal-title":"Cureus"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2020.01.006","article-title":"Histologic comparison of tumor necrosis factor-\u03b1 inhibitor-induced psoriasis and psoriasis vulgaris","volume":"83","author":"Hu JZ","year":"2020","unstructured":"Hu JZ, Billings SD, Yan D, Fernandez AP. Histologic comparison of tumor necrosis factor-\u03b1 inhibitor-induced psoriasis and psoriasis vulgaris. J Am Acad Dermatol. 2020, 83:71-7. 10.1016\/j.jaad.2020.01.006","journal-title":"J Am Acad Dermatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2012.04.011","article-title":"Vasculitis associated with tumor necrosis factor-\u03b1 inhibitors","volume":"87","author":"Sokumbi O","year":"2012","unstructured":"Sokumbi O, Wetter DA, Makol A, Warrington KJ. Vasculitis associated with tumor necrosis factor-\u03b1 inhibitors. Mayo Clin Proc. 2012, 87:739-45. 10.1016\/j.mayocp.2012.04.011","journal-title":"Mayo Clin Proc"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s11739-021-02688-x","article-title":"Diagnosis and management of leukocytoclastic vasculitis","volume":"16","author":"Fraticelli P","year":"2021","unstructured":"Fraticelli P, Benfaremo D, Gabrielli A. Diagnosis and management of leukocytoclastic vasculitis. Intern Emerg Med. 2021, 16:831-41. 10.1007\/s11739-021-02688-x","journal-title":"Intern Emerg Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.7912","article-title":"Leukocytoclastic vasculitis: an early skin biopsy makes a difference","volume":"12","author":"Chango Azanza JJ","year":"2020","unstructured":"Chango Azanza JJ, Calle Sarmiento PM, Lopetegui Lia N, Alexander SA, Modi V. Leukocytoclastic vasculitis: an early skin biopsy makes a difference. Cureus. 2020, 12:e7912. 10.7759\/cureus.7912","journal-title":"Cureus"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.142.11.1407","article-title":"Successful use of rituximab for cutaneous vasculitis","volume":"142","author":"Chung L","year":"2006","unstructured":"Chung L, Funke AA, Chakravarty EF, Callen JP, Fiorentino DF. Successful use of rituximab for cutaneous vasculitis. Arch Dermatol. 2006, 142:1407-10. 10.1001\/archderm.142.11.1407","journal-title":"Arch Dermatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/357462-infliximab-induced-vasculitis-in-a-rheumatoid-arthritis-patient-a-comprehensive-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T17:25:26Z","timestamp":1744910726000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/357462-infliximab-induced-vasculitis-in-a-rheumatoid-arthritis-patient-a-comprehensive-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,17]]},"references-count":10,"URL":"https:\/\/doi.org\/10.7759\/cureus.82467","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4,17]]}}}